NorthStar Healthcare Income, Inc. (NHHS)

NHHS Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	112.94	97.99	-156.89	-54.1	25.07	-261.46
Depreciation & Amortization	35.18	35.99	38.51	38.59	54.84	65.01
Other Amortization	3.31	3.93	4.45	3.88	4.83	4.98
Gain (Loss) on Sale of Assets	0.3	0.3	0.36	-	-	1.75
Gain (Loss) on Sale of Investments	-141.63	-129.85	68.73	12.39	-80.17	-0.43
Asset Writedown	3.01	3.41	44.34	31.88	5.39	164.22
Stock-Based Compensation	0.25	0.24	0.23	8.27	10.72	9.85
Income (Loss) on Equity Investments	-1.52	-2.54	18.91	-25.33	-15.84	34.47
Change in Accounts Receivable	0.1	-0.51	0.63	0.33	1.76	-4.23
Change in Accounts Payable	18.48	14.5	6.63	-5.22	-17.35	8.48
Change in Other Net Operating Assets	-0.36	0.36	-3.9	-2.98	-5.21	8.13
Other Operating Activities	-0.34	-0.39	-3.36	-0.4	9.36	-2.12
Operating Cash Flow	30.33	23.99	19.06	7.82	-6.44	31.02
Operating Cash Flow Growth	28.92%	25.87%	143.63%	-	-	22.61%

Investing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Acquisition of Real Estate Assets	-14.57	-15.98	-39.42	-29.3	-27.77	-15.21
Sale of Real Estate Assets	118.78	43.17	0.14	-	596.41	0.93
Net Sale / Acq. of Real Estate Assets	104.21	27.18	-39.28	-29.3	568.64	-14.29
Investment in Marketable & Equity Securities	253.94	253.94	16.87	44.84	17.71	5.92
Other Investing Activities	0.55	0.55	0.52	-	1.1	-0.05
Investing Cash Flow	358.69	281.67	-21.88	15.54	661.83	-8.42

Financing Activities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-Term Debt Issued	-	-	-	-	26	35
Total Debt Issued	-	-	-	-	26	35
Long-Term Debt Repaid	-	-45.48	-18.64	-21.69	-553.2	-20.86
Total Debt Repaid	-113.44	-45.48	-18.64	-21.69	-553.2	-20.86
Net Debt Issued (Repaid)	-113.44	-45.48	-18.64	-21.69	-527.2	14.14
Repurchase of Common Stock	-	-	-1.32	-	-	-2.08
Common Dividends Paid	-	-	-	-97.02	-	-
Other Financing Activities	-0.95	-0.76	0.06	0.07	-10.82	0.08

Net Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Cash Flow	274.63	259.43	-22.72	-95.28	117.37	34.75

Free Cash Flow

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Levered Free Cash Flow	11.77	-58.28	13.86	34.39	59.11	23.92
Unlevered Free Cash Flow	38.96	-30.45	40.68	57.55	92.79	60.18

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash Interest Paid	33.94	34.66	38.27	38.84	65.83	53.14
Cash Income Tax Paid	0.1	0.1	0.09	0.05	0.1	0.01
Change in Working Capital	18.22	14.34	3.36	-7.87	-20.8	12.38

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error